{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T13:16:51Z","timestamp":1715606211263},"reference-count":37,"publisher":"Informa Healthcare","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2012,10,1]]},"DOI":"10.3111\/13696998.2012.691144","type":"journal-article","created":{"date-parts":[[2012,5,7]],"date-time":"2012-05-07T12:48:59Z","timestamp":1336394939000},"page":"878-886","source":"Crossref","is-referenced-by-count":6,"title":["Economic evaluation of dabigatran etexilate for the primary prevention of venous tromboembolic events following major orthopedic surgery in the Netherlands"],"prefix":"10.3111","volume":"15","author":[{"given":"Maarten J.","family":"Postma","sequence":"first","affiliation":[{"name":"Unit of PharmacoEpidemiology & PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen Groningenthe Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bregt S.","family":"Kappelhoff","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim\rAlkmaarthe Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marinus","family":"van Hulst","sequence":"additional","affiliation":[{"name":"Unit of PharmacoEpidemiology & PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen, Groningen, the Netherlands; and Martini Hospital Groningenthe Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacobus R. B. J.","family":"Brouwers","sequence":"additional","affiliation":[{"name":"Department of Geriatrics-Ephor, University Medical Centre Utrecht, The Netherlands; and Unit of Pharmacotherapy & Pharmaceutical Care, Department of Pharmacy, University of Groningen Groningenthe Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2012,6,7]]},"reference":[{"issue":"6","key":"CIT0001","doi-asserted-by":"crossref","first-page":"381S","DOI":"10.1378\/chest.08-0656","volume":"133","author":"Geerts WH","year":"2008","journal-title":"Chest"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.13.1465"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)05249-1"},{"key":"CIT0004","first-page":"1842","volume":"147","author":"Ettema HB","year":"2003","journal-title":"Ned Tijdschr Geneeskd"},{"key":"CIT0005","first-page":"259-260","volume":"340","author":"Hill J","year":"2010","journal-title":"BMJ"},{"key":"CIT0006","unstructured":"Biiller HR; Richtlijn diagnostiek, preventie en behandeling van veneuze tromboembolie en secundaire preventie van arteri\u00eble trombose. Kwaliteitsinstituut voor de Gezondheidszorg CBO\/Nederlands Huisartsen Genootschap. Utrecht 2008. www.cbo.nl\/Downloads\/492\/rl_stol_09.pdf. Accessed August 5, 2010"},{"key":"CIT0007","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1538-7836.2009.03728.x","volume":"8","author":"Struijk-Mulder MC","year":"2010","journal-title":"J Thromb Haemostas"},{"key":"CIT0008","unstructured":"National Joint Registry for England and Wales 5th Annual Report. 2008; http:\/\/www.njrcentre.org.uk\/njrcentre\/default.aspx. Accessed November 4, 2010"},{"key":"CIT0009","unstructured":"Pharmo Institute. Prevention of thromboembolic disease following knee or hip replacement: \u2018burden of illness\u2019. Utrecht: Pharmo Institute, 2008. http:\/\/www.pharmo.nl\/frames.php?htmlpage=navigatie\/reports.htm. Accessed June 8, 2010"},{"key":"CIT0010","first-page":"128","volume":"4","author":"Kappelhoff BS","year":"2009","journal-title":"Pharm Weekbl Wet Platform"},{"key":"CIT0011","doi-asserted-by":"crossref","first-page":"349S","DOI":"10.1378\/chest.124.6_suppl.349S","volume":"124","author":"Anderson FA","year":"2003","journal-title":"Chest"},{"key":"CIT0012","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3928\/0147-7447-20050201-16","volume":"28","author":"Colwell CW","year":"2005","journal-title":"Orthopedics"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1007\/s00068-002-1176-1"},{"key":"CIT0014","first-page":"15","volume":"13","author":"Muntz JE","year":"2004","journal-title":"J Surg Orthop Adv"},{"key":"CIT0015","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/00016470510030409","volume":"76","author":"Ettema HB","year":"2005","journal-title":"Acta Orthop"},{"key":"CIT0016","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(07)61445-7","volume":"370","author":"Eriksson BI","year":"2007","journal-title":"Lancet"},{"key":"CIT0017","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1111\/j.1538-7836.2007.02748.x","volume":"5","author":"Eriksson BI","year":"2007","journal-title":"J Tromb Haemost"},{"key":"CIT0018","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.thromres.2010.03.021","volume":"126","author":"Friedman RJ","year":"2010","journal-title":"Thromb Res"},{"key":"CIT0019","unstructured":"National Collaborating Centre for Acute Care (NCC-AC). Venous thromboembolism: the prevention of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients undergoing orthopaedic surgery and other high-risk surgical procedures. London: National Collaborating Centre for Acute Care, 2007. http:\/\/www.rcseng.ac.uk\/publications\/docs\/venous_thrombo.html. Accessed November 4, 2010"},{"key":"CIT0020","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMcp052967","volume":"355","author":"Arepally GM","year":"2006","journal-title":"New Engl J Med"},{"key":"CIT0021","unstructured":"Health Care Insurance Board. Dutch pharmacoeconomic guidelines 2004 [in Dutch]. Amstelveen: Health Care Insurrance Board, 2003. http:\/\/www.cvz.nl\/resources\/FARM_richtlijnen_farmaco-economisch_onderzoek_2006_tcm28-19118.pdf. Accessed August 5, 2010"},{"key":"CIT0022","unstructured":"Oostenbrink JB, Bouwmans CAM, Koopmanschap MA, et al. Guideline for costing research, methods and standardized prices for economic evaluations in health care [in Dutch]. Diemen: Health Care Insurance Board, 2004. http:\/\/www.cvz.nl\/resources\/feo_handleiding-kostenonderzoek2004_tcm28-17013.pdf. Accessed December 21, 2010"},{"key":"CIT0023","volume-title":"Decision modelling for health economic evaluation","author":"Briggs A","year":"2008"},{"key":"CIT0024","unstructured":"http:\/\/www.fk.cvz.nl\/. Accessed August 5, 2010"},{"key":"CIT0025","unstructured":"Nederlandse Orthopaedische Vereniging. Diagnostiek en behandeling van heup- en knieartrose, richtlijn [in Dutch]. Nijmegen: Nederlandse Orthopaedische Vereniging, 2007"},{"key":"CIT0026","unstructured":"National Collaborating Centre for Acute Care (NCC-AC). Venous thromboembolism: the prevention of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients undergoing orthopaedic surgery and other high-risk surgical procedures. 2007"},{"key":"CIT0027","unstructured":"http:\/\/www.medicijnkosten.nl\/. Accessed December 20, 2010"},{"key":"CIT0028","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1001\/archinte.164.18.1961","volume":"164","author":"Rice L","year":"2004","journal-title":"Myths and misconceptions. Arch Intern Med"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2007.65"},{"key":"CIT0030","first-page":"S51","volume":"16","author":"Ten Berg M","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"CIT0031","unstructured":"Institute for Medical Technology Assessment. Cost analysis of treatment of adverse events related to treatment of patients with CML. Rotterdam: Institute for Medical Technology Assessment, Erasmus MC, 2007. Report 07.99 (data on file)"},{"key":"CIT0032","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1185\/03007990802443255","volume":"24","author":"Wolowacz SE","year":"2008","journal-title":"Current Med Res Opinion"},{"key":"CIT0033","first-page":"A958","volume":"154","author":"Hoomans T","year":"2010","journal-title":"Nederlands Tijdschrift voor Geneeskunde"},{"key":"CIT0034","unstructured":"www.cvz.nl. Accessed December 21, 2010"},{"key":"CIT0035","first-page":"20","volume":"4","author":"Boersma C","year":"2010","journal-title":"Pharm Weekbl"},{"key":"CIT0036","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1477-9560-9-3","volume":"9","author":"Dranitsaris G","year":"2001","journal-title":"Thromb J"},{"key":"CIT0037","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.06-2109","volume":"131","author":"Smythe MA","year":"2007","journal-title":"Chest"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3111\/13696998.2012.691144","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T16:34:04Z","timestamp":1599410044000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3111\/13696998.2012.691144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,7]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10,1]]}},"alternative-id":["10.3111\/13696998.2012.691144"],"URL":"https:\/\/doi.org\/10.3111\/13696998.2012.691144","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,7]]}}}